[2] [11] As of 2026, retatrutide has not received marketing authorisation from the Medicines and Healthcare products Regulatory Agency (MHRA) or the European Medicines Agency (EMA), and it remains an experimental compound available only within authorised clinical trial settings
For those with subclinical lows
It is generally considered to be safe during pregnancy, but is primarily used in hospital settings during acute situations that require rapid treatment, like severe preeclampsia
This article is for general information only and does not replace personalised medical advice
Athletes typically have heard about these peptides through social media, podcasts or people in their circle who have used them, Frank said
Store at room temperature in a clean, dry environment away from direct sunlight